Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease

Journal Title: Гастроентерологія - Year 2017, Vol 51, Issue 3

Abstract

Background. Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases associated with insulin resistance and metabolic disorders, such as obesity, type 2 diabetes mellitus and dyslipidemia. NAFLD includes simple steatosis, which has a benign course, nonalcoholic steatohepatitis, which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the gold standard for assessing the degree of steatosis, liver inflammation and fibrosis; however, a growing interest in recent years is caused by noninvasive methods, including evaluation of various indices based on serum markers. The purpose of the study was the evaluation of serum markers and noninvasive laboratory indices in identifying morphological changes in the liver of patients with nonalcoholic fatty liver disease. Materials and methods. The study included patients with NAFLD, who underwent examination and treatment in the SI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”. The study involved 60 patients with NAFLD, including 26 (43 %) men and 34 (57 %) women, average age of the patients was (37.1 ± 12.4) and (44.30 ± 7.25) years, respectively. All patients had completed the study of serum hyaluronic acid, α2-macroglobulin, apolipoprotein A1, fibronectin, haptoglobin, calculation of noninvasive indices of liver fibrosis: AAR, APRI, FIB-4, percutaneous core needle liver biopsy with subsequent morphological study of tissues. Results. In patients with NAFLD, we have established a high diagnostic accuracy of serum markers of fibrosis, both in differentiation of various stages of fibrosis and the exclusion of fibrosis presence. Conclusions. Determination of serum markers is important in the choice of treatment, and the correspondence of non-invasive markers to the gold standard — morphological study allows to avoid liver biopsy as a method with potential complications due to its invasiveness.

Authors and Affiliations

Yu. M. Stepanov, N. V. Nedzvetskaya, V. B. Yagmur, I. A. Klenina, N. Yu. Oshmyanskaya

Keywords

Related Articles

Comprehensive therapy of gastroesophageal reflux disease combined with anxiety-depressive states in antiterrorist operation participants

Background. The purpose was to establish the incidence and severity of anxiety-depressive disorders in antiterrorist operation (ATO) participants with different clinical endoscopic forms of gastroesophageal reflux diseas...

Wilson — Konovalov Disease: Diagnostic Algorithms and Approaches to Treatment

Wilson — Konovalov disease is a hereditary disease characterized by progressive accumulation of copper, mainly affecting liver and brain. It is a rare disease and is often diagnosed on later stages, but it is now becomin...

The use of elastography in patients with chronic liver diseases

The article considers the advantages and disadvantages of the non-invasive method for diagnosing liver fibrosis — elastography. The types of this research method, applications were described. The most effective types of...

Efficacy of the Treatment for Anxiety-Depressive Disorders in Patients with Gastroenterological Diseases

The article deals with problem of the treatment of anxiety-depressive disorders in patients with gastroenterological disease and persistent symptoms of abdominal pain and dyspepsia. For objectification of psychoemotional...

Historical Pages of Rendering Medical Help in Katerinoslavschyna — Dnipropetrovschyna

The paper is devoted to the charity of Princess Natalya Cherkaska (birth surname Katerynych) in the end of the ХІХ century in Katerinoslavschyna-Dnipropetrovschyna. N.I. Cherkaska established a hospital and a school in t...

Download PDF file
  • EP ID EP231300
  • DOI 10.22141/2308-2097.51.3.2017.112635
  • Views 79
  • Downloads 0

How To Cite

Yu. M. Stepanov, N. V. Nedzvetskaya, V. B. Yagmur, I. A. Klenina, N. Yu. Oshmyanskaya (2017). Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease. Гастроентерологія, 51(3), 188-195. https://europub.co.uk/articles/-A-231300